XBiotech XBIT Cash Flow Statement (2014-2026)

NASDAQ XBIT
$2.18 +0.03 (+1.40%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

XBiotech Quarterly Cash Flow Statement

Periods 49 quarters
Latest Jun 2026

XBiotech cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 49 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-5.12M-3.26M-6.47M-5.39M-11.64M-12.66M-3.20M-3.89M-8.74M-7.36M-4.63M-10.00M-13.01M-5.01M-10.51M-10.88M-1.76M-6.01M-26.89M-6.73M
Depreciation and Depletion
0.64M0.69M0.70M0.71M0.73M0.73M0.44M0.44M0.43M0.43M0.39M0.43M0.43M0.44M0.44M0.44M0.44M0.43M0.38M
Share-based Compensation
1.04M1.13M1.35M1.45M1.45M1.13M1.04M0.70M0.91M0.95M0.69M0.38M0.38M0.36M0.63M3.33M0.11M0.02M0.16M
Change in Interest Receivables
1.22M1.16M0.85M-2.34M-0.02M0.01M-0.14M-0.03M-0.22M-0.03M-0.09M
Cash from Operations
72.80M-3.40M-1.76M-5.12M-5.39M-1.15M-3.16M-4.81M-9.00M-1.49M-3.43M-7.20M-11.38M-5.84M-6.54M-6.72M-5.99M-4.26M-22.95M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Depreciation & Amortization
0.64M0.69M0.70M0.71M0.73M0.73M0.44M0.44M0.43M0.43M0.39M0.43M0.43M0.44M0.44M0.44M0.44M0.43M0.38M
Change in Working Capital
Change in Receivables
-1.66M0.02M-0.04M0.50M-0.50M1.53M-1.53M
Change in Account Payables
0.38M-0.65M1.17M-0.81M1.03M-0.96M1.10M-1.06M0.44M-0.32M1.03M0.01M-0.82M-0.20M0.65M-1.12M0.33M-0.39M0.49M
Change in Accured Expenses
0.34M-0.04M-0.27M0.19M4.02M-3.60M-0.39M0.60M0.43M1.03M-0.17M0.69M1.15M-0.86M-1.86M1.67M-1.89M0.01M3.90M
Change in Taxes
4.76M2.29M-1.44M1.07M2.40M-11.25M-0.78M0.02M0.01M0.14M-0.65M0.03M0.03M0.01M0.02M0.03M0.03M0.10M-0.39M
Other Working Capital Changes
-2.15M-0.01M0.56M-0.30M-0.09M0.08M-0.02M0.10M0.24M-0.07M-0.12M0.31M0.04M-0.07M-0.01M0.12M0.16M-0.25M-0.02M
Investing Activities
Capital Expenditures
1.71M0.70M0.48M0.16M0.08M0.21M0.13M0.01M0.21M0.03M0.12M0.26M0.63M0.34M0.08M0.09M0.05M0.11M0.03M
Cash from Investing Activities
-1.71M-0.70M-0.48M-0.16M-0.08M-59.74M-3.91M-0.01M-0.21M61.83M-0.12M-0.26M-0.63M-0.34M-0.08M-0.09M-0.05M-0.11M-0.03M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances
10.00M0.25M-10.00M-0.25M
Change in Capital Stock
Net Equity Issued and Repurchased
3.98M2.96M0.03M0.01M0.06M0.05M0.06M0.03M
Misc.
Cash from Financing Activities
3.98M-72.04M0.03M-0.01M0.01M10.05M0.05M0.06M0.28M-10.25M
Exchange Rate Effect
0.32M-0.24M0.31M0.12M-0.56M-4.33M3.81M-0.01M0.13M-1.54M1.38M
Change in Cash
75.38M-76.38M-1.89M-5.16M-6.03M-65.22M-3.26M-4.82M-9.09M58.80M-2.17M1.02M-12.51M-5.41M-10.44M-16.78M-2.96M-5.57M-21.82M
Free Cash Flow
71.08M-4.10M-2.23M-5.28M-5.47M-1.36M-3.30M-4.81M-9.21M-1.52M-3.55M-7.46M-12.00M-6.18M-6.62M-6.81M-6.04M-4.37M-22.99M
Net Cash Flow
75.06M-76.14M-2.20M-5.28M-5.47M-60.89M-7.07M-4.81M-9.22M60.34M-3.55M2.60M-11.96M-6.12M-6.34M-17.06M-6.04M-4.37M-22.99M

XBiotech Cash Flow Statement API

Pull XBiotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=XBIT&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY